Effect of Oxytocin Infusion on Reducing the Blood Loss During Abdominal Myomectomy: A Double-Blind Randomised Controlled Trial Publisher Pubmed



Atashkhoei S¹ ; Fakhari S¹ ; Pourfathi H¹ ; Bilehjani E¹ ; Garabaghi PM¹ ; Asiaei A¹ Show Affiliations
Source: BJOG: An International Journal of Obstetrics and Gynaecology Published:2017

Abstract

Objective: To assess the effectiveness and safety of oxytocin to reduce blood loss during abdominal myomectomy. Design: Double-blind randomised controlled trial. Setting: Obstetrics and Gynecologic University Medical Centre. Population: Eighty healthy women candidates for abdominal myomectomy. Methods: Women were randomly assigned to two groups. In the study group (n = 40) oxytocin 30 IU in 500 ml normal saline; and in the placebo group (n = 40) pure normal saline was administered during myomectomy. The main outcome measures were peri-operative blood loss and rates of blood transfusion. Main outcome measure: Estimated intra-operative blood loss. Results: Estimated intra-operative blood loss in the study group (189.5 ± 16.72 ml) was significantly lower than the placebo group (692.25 ± 89.93 ml) (95% CI 672.54–711.96; P < 0.0001).The need for blood transfusion was significantly lower in the study group. Blood transfusions were required for three (7.5%) women in the study group and 10 (25%) women in the placebo group (95% CI 15.5–34.5; P < 0.001). Conclusions: Intra-operative oxytocin infusion appears to be safe and effective in decreasing blood loss during abdominal myomectomy. Tweetable abstract: Intra-operative oxytocin is effective in decreasing blood loss during abdominal myomectomy. © 2016 Royal College of Obstetricians and Gynaecologists